Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 5Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Nausea 2Multiple Myeloma 2Cachexia 2Anorexia 2Weight Loss 1Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Prosthesis Failure 1Opioid-Related Disorders 1Nutrition Disorders 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Cancer 1

Interventions

Palonosetron 2Electroacupuncture 2Thalidomide 1Taxes 1Olanzapine 1Imagery, Psychotherapy 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Vomiting × Olanzapine × Clear all
NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

The Hospital for Sick Children

Phase 2 Recruiting
200 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡